Pharmacological effects of Chinese herb aconite (Fuzi) on cardiovascular system
Authors:
- Jie WangJWJie Wang
- Yanjing CuiYCYanjing Cui
- Xinfang WuXWXinfang Wu
Open Access
- 1 September 2012
- journal article
- review article
- Published by Elsevier in Journal of Traditional Chinese Medicine
- Vol. 32 (3) , 308-313
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- The role of inflammatory and fibrogenic pathways in heart failure associated with agingHeart Failure Reviews, 2010
- Cardiovascular disease in patients with inflammatory rheumatic disease is associated with up‐regulation of markers of inflammation in cardiac microvessels and cardiomyocytesArthritis & Rheumatism, 2010
- Polysaccharide from Fuzi (FPS) Prevents Hypercholesterolemia in RatsLipids in Health and Disease, 2010
- Effects of higenamine and its 1-naphthyl analogs, YS-49 and YS-51, on platelet TXA2 synthesis and aggregationThrombosis Research, 2007
- Higenamine reduces apoptotic cell death by induction of heme oxygenase-1 in rat myocardial ischemia-reperfusion injuryApoptosis, 2006
- The Effects of Higenamine on LPS-Induced Experimental Disseminated Intravascular Coagulation (DIC) in RatsPlanta Medica, 2002
- Antithrombotic Effects of YS-49 and YS-51—1-Naphthylmethyl Analogs of HigenamineThrombosis Research, 2001
- Anti-Thrombotic Effects of HigenaminePlanta Medica, 2001
- Prevention of the expression of inducible nitric oxide synthase by a novel positive inotropic agent, YS 49, in rat vascular smooth muscle and RAW 264.7 macrophagesBritish Journal of Pharmacology, 1999
- Cardioactive Principle of Aconitum carmichaeli Roots1Planta Medica, 1979